Security key
77313F106
ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)
CUSIP: 77313F106
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 109,265,652
- Total 13F shares
- 78,264,099
- Share change
- +2,794,774
- Total reported value
- $1,340,378,412
- Put/Call ratio
- 27%
- Price per share
- $17.13
- Number of holders
- 161
- Value change
- +$44,795,861
- Number of buys
- 87
- Number of sells
- 54
Report period
Q1 2023
Institutions
161
Top holders
10
RCKT full security history
Newer quarter: Q2 2023
Previous quarter: Q4 2022
ROCKET PHARMACEUTICALS, INC. SEC filings
ROCKET PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 77313F106
Recent filing periods:
Top shareholders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
16%
|
17,687,772
|
$346,149,698 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.1%
|
5,587,535
|
$109,348,060 | — | 31 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.8%
|
4,186,542
|
$81,930,626 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
3.6%
|
3,978,985
|
$77,868,736 | — | 31 Dec 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.2%
|
3,507,017
|
$68,632,322 | — | 31 Dec 2022 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
3.1%
|
3,395,818
|
$66,456,158 | — | 31 Dec 2022 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
2.7%
|
2,905,555
|
$56,861,711 | — | 31 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.4%
|
2,602,680
|
$50,934,448 | — | 31 Dec 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.2%
|
2,407,149
|
$47,107,906 | — | 31 Dec 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.7%
|
1,886,290
|
$36,914,000 | — | 31 Dec 2022 | |
| Avidity Partners Management LP |
13F
|
Company |
1.4%
|
1,527,087
|
$29,885,093 | — | 31 Dec 2022 | |
| Boxer Capital, LLC |
13F
|
Company |
1.3%
|
1,466,051
|
$28,690,618 | — | 31 Dec 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1%
|
1,128,361
|
$22,083,000 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
1,101,320
|
$21,552,000 | — | 31 Dec 2022 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
1%
|
1,100,000
|
$21,527,000 | — | 31 Dec 2022 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.99%
|
1,078,204
|
$21,100,452 | — | 31 Dec 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.94%
|
1,029,164
|
$20,140,737 | — | 31 Dec 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.92%
|
1,005,322
|
$19,674,000 | — | 31 Dec 2022 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.79%
|
868,550
|
$16,998,000 | — | 31 Dec 2022 | |
| Novo Holdings A/S |
13F
|
Company |
0.78%
|
850,000
|
$16,634,500 | — | 31 Dec 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.78%
|
847,321
|
$16,582,000 | — | 31 Dec 2022 | |
| Logos Global Management LP |
13F
|
Company |
0.69%
|
750,000
|
$14,677,500 | — | 31 Dec 2022 | |
| M28 Capital Management LP |
13F
|
Company |
0.66%
|
722,080
|
$14,131,106 | — | 31 Dec 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.61%
|
661,515
|
$12,945,848 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.5%
|
541,303
|
$10,593,300 | — | 31 Dec 2022 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.49%
|
535,588
|
$10,482,000 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.49%
|
534,352
|
$10,457,271 | — | 31 Dec 2022 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.48%
|
522,345
|
$10,222,292 | — | 31 Dec 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.46%
|
503,721
|
$9,858,000 | — | 31 Dec 2022 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.43%
|
470,654
|
$9,210,699 | — | 31 Dec 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.41%
|
447,851
|
$8,764,444 | — | 31 Dec 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.39%
|
422,175
|
$8,261,965 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.35%
|
387,175
|
$7,577,015 | — | 31 Dec 2022 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.35%
|
380,046
|
$7,437,499 | — | 31 Dec 2022 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.34%
|
371,300
|
$7,266,341 | — | 31 Dec 2022 | |
| NORGES BANK |
13F
|
Company |
0.29%
|
320,773
|
$6,277,528 | — | 31 Dec 2022 | |
| UBS Group AG |
13F
|
Company |
0.27%
|
295,261
|
$5,778,258 | — | 31 Dec 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.27%
|
293,961
|
$5,752,817 | — | 31 Dec 2022 | |
| COMERICA BANK |
13F
|
Company |
0.26%
|
288,316
|
$6,360,000 | — | 31 Dec 2022 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.26%
|
284,433
|
$5,566,354 | — | 31 Dec 2022 | |
| TIGER MANAGEMENT L.L.C. |
13F
|
Company |
0.26%
|
279,700
|
$5,473,729 | — | 31 Dec 2022 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.24%
|
260,000
|
$5,088,200 | — | 31 Dec 2022 | |
| FMR LLC |
13F
|
Company |
0.24%
|
259,160
|
$5,071,761 | — | 31 Dec 2022 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.24%
|
258,115
|
$5,051,311 | — | 31 Dec 2022 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
251,698
|
$4,925,730 | — | 31 Dec 2022 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.22%
|
238,834
|
$4,647,710 | — | 31 Dec 2022 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.2%
|
222,000
|
$4,344,540 | — | 31 Dec 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.2%
|
220,253
|
$4,310,351 | — | 31 Dec 2022 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.17%
|
190,790
|
$3,733,760 | — | 31 Dec 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.17%
|
189,468
|
$3,707,889 | — | 31 Dec 2022 |
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) as of Q1 2023
As of 31 Mar 2023,
ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) was held by
161 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
78,264,099 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, BlackRock Inc., VANGUARD GROUP INC, MAVERICK CAPITAL LTD, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, WESTFIELD CAPITAL MANAGEMENT CO LP, CITADEL ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, and GOLDMAN SACHS GROUP INC.
This page lists
161
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
167
Q1 2023 holders
161
Holder diff
-6
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.